ESCRS - P222 - EARLY RESULTS AFTER OF MICROSTENT HYDRUS COMBINED WITH CATARACT OPERATION AND STANDALONE PROCEDURE IN PSEUDOPHACIC EYE

EARLY RESULTS AFTER OF MICROSTENT HYDRUS COMBINED WITH CATARACT OPERATION AND STANDALONE PROCEDURE IN PSEUDOPHACIC EYE

Published 2022 - 26th ESCRS Winter Meeting

Reference: P222 | Type: Abstracts | DOI: 10.82333/5mz6-jy10

Authors: Magda Rau* 1

1Augenklinik Cham,Privatklinik Dr.Rau,Augenklinik Cham,Cham,Germany

Purpose

Assessment of reduction of IOP and number of medication after implantation of Hydrus (Ivantis) in the patients with open angle glaucoma. The implantation was performed combined with cataract operation or a stand-alone procedure. Additionally the safety of the procedure was assessed

Setting

Augenklinik Cham,Germany

Methods

From October 2020 to January 2021 we have implanted at a single centre by a single surgeon with and without cataract surgery Micro Stent Hydrus (Ivantis )in 10eyes of 8 patients,in 2 combined with cataract surgery,8 implantation as Stand alone procedure in pseudophacic eyes.

Results

The mean preoperative pressure IOP was 34,5 mmHg and  average number of IOP lowering medication      was 3.The IOP could be reduced on the first postoperative day to 12,9mmHg,after 6 months the average IOP was 12,4 mmHg.The number of mediacation could be reduced from 3 to 1 after 3 and 6 months.

Conclusion

Implantation of the  Micro-Stent Hydrus in combination with cataract surgery or as stand alone procedure is a safe, microinvasive treatment of open-angle glaucoma .No patients experienced sight-threatening adverse events .With respect to reduction of IOP and glaucoma medications after 6 months , it is an effective and lasting procedure